Lloyd’s 2022 medical start-up syndicate seeks ILS, Names capital
The former QBE underwriting team behind the 1.1.22 Lloyd’s medical start-up syndicate are expected to attract backing from both ILS funds and third-party Names’ capital, The Insurer can reveal.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below